SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood shares are facing significant volatility as investors react to a double earnings miss, with sentiment split between those viewing the pullback as a buying opportunity and critics concerned about the company's heavy reliance on crypto market cycles. While community debate remains heated regarding the stock's long-term valuation and historical controversies, many are closely watching management's pivot toward prediction markets and subscriber growth for signs of a turnaround.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is experiencing significant retail and institutional attention ahead of its upcoming earnings report, with the community actively debating whether the stock will trigger a short squeeze or face continued downward pressure similar to other fintech sector peers. Traders are fixated on key metrics like revenue growth, member expansion, and potential guidance, while the community remains polarized between long-term "bulls" expecting a breakout and skeptical "bears" highlighting the stock's recent volatility and valuation concerns.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate Technology is experiencing significant market attention as strong AI-driven storage demand and record-breaking financial performance confirm a structural boom in the memory and storage sector. The community is actively debating the sustainability of this parabolic rally, with many investors weighing aggressive momentum plays against concerns over stretched valuations and historical sector cycles.

Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. It operates through the Biopharmaceutical and Strategic Investments segments. The Biopharmaceutical segment focuses on furthering the research and development of the drug candidates and the development of a treatment for alcohol misuse for application in hospitals and other medical practices. The Strategic Investments segment is involved in the generation of returns and cash flow through the issuance of loans secured by residential property, with FSD Strategic Investments having a first or second collateral mortgage on the secured property. The company was founded by Thomas Fairfull, Zeeshan Saeed, and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)

Quantum BioPharma Ltd

Quantum BioPharma is facing intense market speculation driven by a high-stakes lawsuit against major financial institutions regarding alleged stock spoofing, while simultaneously advancing its Lucid-MS clinical pipeline. Community sentiment is deeply polarized, with some investors betting on a short squeeze fueled by legal developments, while critics highlight concerns over historical volatility, management credibility, and the company's path to commercial revenue.

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp is trending as investors capitalize on its status as a low-float, high-volatility play, fueling intense community debate over its potential for a short squeeze versus fears of upcoming dilution. The stock remains a focal point for day traders who are actively tracking breakout levels and monitoring massive borrow fees while debating the sustainability of its recent momentum.

HashPack is the leading retail wallet on Hedera Hashgraph with a fantastic user experience for defi, NFTs and dApps. The wallet is non-custodial, audited and features free email account creation as well as seed phrase based account creation. HashPack is integrated with every major dApp in the Hedera Hashgraph ecosystem and is deeply involved in the retail and developer communities.

HashPack

HashPack is trending as it evolves from a standard Hedera wallet into a multi-chain financial hub, recently bolstered by the addition of in-app cross-chain swaps and an upcoming crypto debit card. The community is actively discussing the platform's role as a primary distribution layer for Web3, with significant focus on the recent token listing on Kraken and the impact of email-based wallet creation on user adoption.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is surging as the market increasingly views it as a critical infrastructure provider for AI data centers, fueled by an expanded partnership with Oracle and a record-breaking backlog that underscores its ability to meet the urgent power demands of hyperscalers. Investors are actively discussing the stock's parabolic move and the strategic shift toward 'bring-your-own-power' solutions, while some voice concerns over valuation and the potential for equity dilution as the company continues to scale.

Rayls is a Layer-1 blockchain ecosystem designed for financial institutions to bridge traditional finance (TradFi) and decentralized finance (DeFi). Developed by Parfin, Rayls combines a public chain, private networks, and institutional privacy nodes into a unified infrastructure that supports compliant, scalable, and privacy-preserving asset tokenization and settlement. Its architecture connects regulated banks and payment systems with public DeFi liquidity while maintaining confidentiality through the Rayls Enygma privacy protocol. The network enables tokenization of real-world assets, CBDCs, and stablecoins using EVM-compatible technology, fixed USD-pegged gas fees, deterministic finality, and harmful MEV protection.

Rayls

Rayls is currently seeing significant community activity as investors anticipate its upcoming mainnet launch, with many traders closely monitoring volume and price action for potential breakout opportunities. While some participants express caution and skepticism regarding recent volatility, others remain bullish on its long-term potential as a privacy-driven financial infrastructure layer.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is attracting intense community interest as it pivots into AI data center infrastructure with its new IQ Solid-State Transformer, while the stock grapples with significant post-earnings volatility and broader concerns over solar market demand. Investors remain sharply divided, debating whether the company is a long-term infrastructure play or a speculative trap as they weigh the potential for a rebound against lingering headwinds like tax credit expiration and sector-wide weakness.

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquisition, development, and commercialization of drug candidates for medical dermatology and respiratory diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.

Edesa Biotech Inc

Edesa Biotech is experiencing significant volatility and community discussion as traders debate the potential for a biotech buyout versus the risks of share dilution or further retracement. Investors are closely monitoring the stock's clinical pipeline, specifically the EB05 asset, while tracking institutional activity and pending conference presentations that could serve as a catalyst for a sustained move.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of InspireMD, Inc. (NASDAQ: NSPR)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of InspireMD, Inc. (NASDAQ: NSPR) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of...

After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR)

InspireMD (NSPR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

InspireMD (NYSE:NSPR) Trading Down 6.7% - What's Next?

InspireMD (NYSE:NSPR) Shares Down 6.7% - Time to Sell...

InspireMD, Inc. (NSPR) Reports Q4 Loss, Beats Revenue Estimates

InspireMD (NSPR) delivered earnings and revenue surprises of +36.36% and +14.93%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

921,587 Shares in InspireMD, Inc. $NSPR Purchased by Ghisallo Capital Management LLC

Ghisallo Capital Management LLC purchased a new position in InspireMD, Inc. (NYSE:NSPR - Free Report) during the 3rd quarter, according to its most recent filing with the Securities & Exchange...

Rosalind Advisors Inc. Purchases 1,616,644 Shares of InspireMD, Inc. $NSPR

Rosalind Advisors Inc. lifted its position in InspireMD, Inc. (NYSE:NSPR - Free Report) by 70.6% during the third quarter, according to the company in its most recent filing with the Securities...

Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates

Stereotaxis (STXS) delivered earnings and revenue surprises of +5.21% and -5.55%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

NeuroPace, Inc. (NPCE) Reports Q4 Loss, Beats Revenue Estimates

NeuroPace (NPCE) delivered earnings and revenue surprises of +41.48% and +2.47%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Penumbra (PEN) Surpasses Q4 Earnings and Revenue Estimates

Penumbra (PEN) delivered earnings and revenue surprises of +5.36% and +6.74%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Aberdeen Group plc Makes New Investment in InspireMD, Inc. $NSPR

Aberdeen Group plc bought a new stake in shares of InspireMD, Inc. (NYSE:NSPR - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange...

InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Miami, FL.

NSPR
InspireMD Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest NSPR News

NSPRInspireMD Inc